| Issue Date | Title | Author(s) |
| 2015 | Association study of genetic polymorphisms of vasoactive hormones with the risk of preeclampsia | Polonikov, A.; Elykova, A.; Sorokina, I.; Efremova, O.; Churnosov, M. |
| 2018 | Candidate genes and clinical-laboratory indices in pregnant women depending on the development of preeclampsia | Reshetnikov, E. A.; Kulikovskii, V. F.; Batlutskaya, I. V.; Iakunchenko, T. I.; Churnosov, M. I. |
| 2018 | Candidate genes and clinical-laboratory parameters in pregnant women with preeclampsia | Reshetnikov, E. A.; Sorokina, I. N.; Krikun, E. N.; Orlova, L. S.; Evdokimov, V. I. |
| 2015 | Correction of adma-induced preeclampsia with the use of phosphodiesterase 5 and selective inhibitor of arginase II ZB49-0010 | Gureev, V. V.; Martynova, O. V.; Anciferova, O. E.; Martynov, M. A.; Pokrovskaia, T. G. |
| 2015 | Correction of adma-induced preeclampsia with the use of phosphodiesterase 5 and selective inhibitor of arginase II ZB49-0010 | Gureev, V. V.; Pokrovskii, M. V.; Korokin, M. V.; Gudyrev, O. S.; Philippova, O. V.; Dolzhikov, A. A.; Lazareva, G. A. |
| 2018 | Correction of morphofunctional disturbances arising when modelling Preeclampsia with resveratrol and nicorandil | Stupakova, E. G.; Lazareva, G. A.; Gureev, V. V. |
| 2008 | Development of endothelial dysfunction in system Mother-Placenta-Fetus at hypertensive disease in gravidae | Pavlova, T. V.; Selivanova, A. V. |
| 2016 | Expression of indaleamine 2,3-dioxygenase mRNA in patients with spontaneous miscarriages at early stages of pregnancy | Lebedeva, O. P.; Yakovleva, O. N.; Pakhomov, S. P.; Churnosov, M. I.; Korotkikh, I. N. |
| 2020 | Functionally significant polymorphisms of ESR1and PGR and risk of intrauterine growth restriction in population of Central Russia | Golovchenko, O.; Abramova, M.; Ponomarenko, I.; Reshetnikov, E.; Aristova, I.; Churnosov, M. |
| 2018 | Genetic determinants of complicated pregnancy | Reshetnikov, E. A.; Rudyh, N. A.; Batlutskaya, I. V.; Krikun, E. N.; Orlova, V. S. |
| 2018 | Genetic factors of pregnancy pathology | Reshetnikov, E. A.; Sorokina, I. N.; Krikun, E. N.; Bushueva, O. Yu.; Polonikov, A. V. |
| 2014 | Issues in the study of utero-placental blood flow in severe gestosis | Pavlova, T. V.; Petrukhin, V.; Selivanova, A.; Goncharov, I.; Kolesnicov, D. |
| 2018 | Polymorphisms of genes and the risk of preeclampsia | Reshetnikov, E. A.; Sorokina, I. N.; Batlutskaya, I. V.; Krikun, E. N.; Pahomov, S. P. |
| 2015 | The effect of humoral factors released by hypoperfused placenta on fetal development | Gureev, V. V.; Antseferova, O. Y.; Lokteva, T. I.; Dolzhikov, A. A. |
| 2018 | The level of fibrinogen and gene polymorphism in pregnant women with placental insufficiency | Reshetnikov, E. A.; Orlova, L. S.; Batlutskaya, I. V.; Rudyh, N. A.; Churnosov, M. I. |
| 2020 | The relationship between placental gene polymorphisms and preeclampsia risk in Russian women | Reshetnikov, E. A.; Altukhova, O. B.; Orlova, V. S.; Batlutskaya, I. V.; Elykova, A. V.; Kulikovskiy, V. F. |
| 2019 | The study of the role of maternal and fetal risk factors in the development of placental insufficiency | Reshetnikov, E. A.; Golovchenko, O. V.; Bezmenova, I. N.; Orlova, V. S.; Batlutskaya, I. V.; Krikun, E. N. |
| 2021 | The use of atomic force microscopy in comprehensive assessment of the "mother-placenta-fetus" system in obstetric and endocrine pathology during pregnancy | Pavlova, T. V.; Shchegolev, A. I.; Malyutina, E. S.; Selivanova, A. V.; Zemlyanskaya, L. O. |
